The Fletikumab Biosimilar Anti-IL20 Antibody offered by Assay Genie is a revolutionary tool for researchers studying IL20, a cytokine involved in regulating immune responses and inflammation. This biosimilar antibody, developed through extensive research and validation, specifically targets IL20, allowing for precise detection and analysis in various experimental settings.IL20 has been implicated in numerous inflammatory conditions, including autoimmune diseases and skin disorders. By targeting IL20 with this biosimilar antibody, researchers can gain valuable insights into the role of IL20 in these diseases and potentially identify new therapeutic targets for treatment.
With its high specificity and sensitivity, the Fletikumab Biosimilar Anti-IL20 Antibody is a critical tool for advancing research in immunology, inflammation, and chronic inflammatory conditions. Its potential applications in drug development and personalized medicine make it a valuable asset for any laboratory studying IL20 and its impact on immune regulation.
Product Name:
Fletikumab (Anti-IL20) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0117
Target:
IL20
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
15D2, NN-8226, NNC-0109-0012
Description:
Anti-IL20(fletikumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
